Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Safety and Efficacy of Urtica Dioica Cataplasm in the Management of Osgood-Schlatter Disease in Young Athletes: A Study Protocol for Randomized, Double-blind, Placebo Controlled Clinical Trial

NCT07096037 is registered in ClinicalTrials.gov with Faculty of Medicine, Sousse as lead sponsor.

NCT NCT07096037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07096037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Safety and Efficacy of Urtica Dioica Cataplasm in the Management of Osgood-Schlatter Disease in Young Athletes: A Study Protocol for Randomized, Double-blind, Placebo Controlled Clinical Trial
Lead sponsor
Faculty of Medicine, Sousse
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2025
Completion date
September 30, 2026
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

osgood-schlatter disease